Tag: OBESITY

zepbound sleep apnea
Sleep Pharmaceuticals Obstructive Sleep Apnea

FDA Approves Zepbound for Obstructive Sleep Apnea with Obesity

Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity.1 Zepbound may help adults with moderate-to-severe obstructive sleep apnea and obesity improve their sleep disorder. It should be used with […]